chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experiencing pain at injection site, unable to move left arm due to muscle ache.  Has tried cold compresses and Tylenol to relieve symptoms. The cold compress has helped a lot but Tylenol has not helped at all. Recommended for her to continue cold compress and ibuprofen. Patient is calling back, her symptoms have improved. She will go to another Publix location to get the 2nd vaccine, as she believes that the person administering the shot pinched a nerve.
Blood clot in right foot. Swelling. I didn't immediately consider the possible connection to the Pfizer vac. Sorry for the delay.
Sore arm for a couple days after shot 1.  Sore arm for a few days after shot 2. Body aches, tired, a little fuzzy headed the following day.  Sometime in the past few weeks (I'm not sure when) I've developed pulsatile tinnitus in my left ear. It comes and goes. It's not very bad and usually only happens when I'm lying down in bed in the evenings. It feels like there's a little extra ear wax or cotton or something in that ear all the time though. I've never had tinnitus prior to this.
Extreme diarrhea 3-5 times (pure liquid) a day since a few days after vaccine, constant rumbling and cramping and the feeling of extreme heat in my stomach.  Gas with uncontrollable diarrhea.  I?ve began taking fiber supplements, probiotics, prebiotic, vitamin c, d3, and zinc, diarrhea is still occurring to this day 9/3 . Intensity and frequency has subsided but mentioned  is still correcting at least 2 time a day
10 hrs after shot, slight headache & start of stuffy sinus 24 hrs increased stuffiness and headache. 48 hrs ache in some joints, headache worse in sinus area. 72 hrs sweats and chills headache and excess mucus. 96 hrs dull headache fading, mucus decreasing, starting to feel better.
Moderna COVID-19 Vaccine EUA delayed injection site reaction - one week after the injection a red, itchy patch developed at and below the injection site the patch is about 3" long and 2" wide
Patient called this morning at approximately 10am and stated she had pain in her left arm and upon taking off her Band-Aid, she saw a large amount of blood on the Band-Aid. I reassured her I didn't see much when I did give her the vaccine, but it could have occurred after she left. She stated she felt some tingling down her arm to her fingers and has pain up towards the clavicle bone (she stated more towards the muscle near the clavicle area). She stated she has no fever and there is no redness around the injection site. She described the pain around the clavicle as "tight" like a sprained ankle. I told patient she could call her primary care physician for any pain medication she needed and rehabilitation of the shoulder if needed.
My dad died on February 19th after having been visibly sick immediately after being vaccinated until the day he died, according to his friends. Was told by a friend that he dropped something he was holding while hanging out with friends and they called an ambulance but he refused the ambulance. I do not know that exact date of that incident only that it was following vaccination.  Was also told by numerous others that he seemed "sick". No other details are known.
GI issues; chills; metallic taste; metallic taste; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from a sales representative.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "hypertriglyceridemia" (unspecified if ongoing); "PMH" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed, Manufacturer Unknown), for Covid-19 Immunization. The following information was reported: GASTROINTESTINAL DISORDER (non-serious), outcome "unknown", described as "GI issues"; CHILLS (non-serious), outcome "unknown"; DYSGEUSIA (non-serious), PRODUCT TASTE ABNORMAL (non-serious), outcome "unknown" and all described as "metallic taste".  Additional information: Event took place after use of product.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was coming in for second primary dose 6m-4yr of pfizer and instead unintentionally received the bivalent booster for pfzizer. No symptoms or reactions known at this time.
Client verbalized swollen lower right lid with redness.  According to patient no pain present.  Client was evaluated by Fire Rescue.  Client was given cold compress by paramedics to apply to swollen lid.
Information has been received from a health professional concerning a male child who on 16-SEP-2006 was vaccinated with an oral 2 ml second dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine). "Ten days after" on 26-SEP-2006 the patient was vaccinated with a third 2 ml oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine) (Lot #654489/0941F). The patient was not experiencing any known symptoms. No product quality complaint was involved. No other information was provided. Additional information has been requested.
At around 1:30 pm I noticed significant swelling and mild pain in my left parotid gland (the same side of my body where the vaccine had been administered).  The swelling was sudden developing over no more than thirty minutes.  The swelling is roughly marble sized.  After consulting with a colleague, we deemed it highly probable that it was vaccine related.  I am currently resting and if I see no improvement by tomorrow, I will see my primary care provider.
significant sore arm that protruded to her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (significant sore arm that protruded to her shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (significant sore arm that protruded to her shoulder). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (significant sore arm that protruded to her shoulder) outcome was unknown.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were unspecified. The reporter stated that from 25-OCT-2015, ZOSTAVAX (lot number L011533, expiration date 03-JUL-2016) was improperly exposed to 46F for 72 hours. Then on 30-OCT-2015, the patient was vaccinated with the improperly stored dose of ZOSTAVAX (dose unknown, subcutaneous). No known adverse effects were reported. No PQC involved. Additional information has been requested.
painful feel in arm, around that shot, had the injection, start itchy start feel itchy/ he told that oh it's only 2-3 nights then go away, they were nothing; painful feel in arm, around that shot, had the injection, start itchy start feel itchy/ he told that oh it's only 2-3 nights then go away, they were nothing; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. It was reported that the painful feel in arm, around that shot, had the injection, start itchy start feel itchy. The consumer's neighbor, they also, her husband also had the injec (incomplete word), meant vaccine shot, the consumer asked her husband, he told that oh it's only 2-3 nights then go away, they were nothing. The outcome of the events was recovered.  Information about Lot/batch number is requested.
Pt arrived from outlying ER with acute chest pain. Pt has a history of COPD and type 2 DM.  COVID-19 was positive enroute.
Wife called to report that patient developed a generalized rash throughout the body the night after receiving Moderna Covid shot.  She provided him with Benadryl.  Next morning his face was swollen and she decided to call the pharmacy. I advised her to provided Benadryl again and to take him to emergency room.  Difficult breathing was not reported.
Abrupt temperature spike to 38 C ten minutes post Rubella vax. No rash on body. No swelling or difficulty breathing. No tachycardia, or hypotension was noted.
Initial information received from literature on 27-Sep-2018. Abstract: Serious adverse events after immunizations are rare. We review the case of a man who, 50 years earlier, experienced a serious adverse neurologic event 2 weeks after receiving influenza vaccine. He had received no subsequent seasonal influenza vaccinations, but after the risks and benefits were considered, he was vaccinated without adverse event that season. This case involves a male patient (age not reported) who experienced adverse neurologic event, while he received vaccine INFLUENZA VACCINE. The patient's past medical history and concomitant medication were not reported. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported. On an unknown date (reported as 50 years earlier), The patient developed a serious adverse neurologic event (neurological symptom) 2 weeks following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. The patient had received no subsequent seasonal influenza vaccinations, but after the risks and benefits were considered, he was vaccinated without adverse event that season. No lab tests reported. Final diagnosis was adverse neurologic event. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for adverse neurologic event.; Sender's Comments: This literature article describes a patient of unknown age who experienced unspecified neurologic event post vaccination with INFLUENZA VACCINE produced by unknown manufacturer. Time to onset is unknown. Additional information including patient's medical history, condition at the time of vaccination, vaccine and reaction details, lab/radiological test ruling out alternate etiologies especially neurological are needed for complete assessment of the case. Based on available information the role of vaccine cannot be assessed.
pt recv vax 28MAY96 & 8MAY97 pt devel 10 to 15 lesions;pt recovered;
headache, feeling "sore", suddenly feeling very tired "like I could go to sleep right here."
weight loss; no appetite; breathing is shallow; low oxygen 89%; muscle aches; imbalanced; can't sleep; blood pressure down/128/68/and 132/76; weird dreams; minimal injection site pain; This is a spontaneous report from a contactable pharmacist. A 77-years-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection) via an unspecified route of administration, administered in Arm Right on 13Feb2021 17:15 (Batch/Lot Number: EL9209) as single dose for covid-19 immunisation. patient medical history about 20 years ago for a torn ACL and also general surgery. Concomitant medication(s) included levothyroxine taken 100 ug once a day for an unspecified indication from 2018 and ongoing; atorvastatin (LIPITOR) oral 100 mg, once a day taken for blood cholesterol increased from an unspecified start date and ongoing and vitamins Cs and Bs as supplements. The patient experienced minimal injection site pain on 14Feb2021, can't sleep, blood pressure down 128/68/and 132/76, no appetite, breathing is shallow, muscle aches, imbalanced, low oxygen 89% and weird dreams on 26Mar2021. weight loss on 27Mar2021. The patient underwent lab tests and procedures which included blood pressure measurement: 128/68 on 26Mar2021, body temperature: 98.3 on 26Mar2021, oxygen saturation: 89 % on 26Mar2021, blood pressure measurement: 132/76 on 28Mar2021, body temperature: 98.3 on 28Mar2021 and oxygen saturation: 95-96 % on 28Mar2021, body temperature: 100.8 on an unspecified date and oxygen saturation: 96 % on 29Mar2021. The report considered as a serious. The outcome of the events can't sleep , weight loss, no appetite, breathing is shallow, muscle aches, imbalanced and weird dreams was reported as not recovered, minimal injection site pain was reported as recovered as 15Feb2021 . blood pressure down/128/68/and 132/76 and low oxygen 89% was reported as recovering,; Sender's Comments: Based on temporal association, a contributory role of  bnt162b2 to the reported events cannot be completely excluded. The case will be reassessed once more information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
This spontaneous report was received from a pharmacist refers to a 5-5year-old female patient. The patient was vaccinated with, 0.5 milliliter (ml) PNEUMOVAX 23 (lot # 1947AA, expiration date 20-OCT-2013) unspecified dose intramuscularly on 02-OCT-2012. Concomitant medications included OXYCODONE, METHADONE HYDROCHLORIDE and ESTRADIOL. No pertinent medical history, drug reactions/allergies were reported. The pharmacist reported that a patient developed pain, redness and warmth at the injection site after receiving a dose of PNEUMOVAX 23 on 02-OCT-2012. Treatment was given for the events, TYLENOL and ice treatment were given. The patient sought medical attention by calling the pharmacist. The events did not resolved at the time of this report. Additional information is not expected.
Administered dose more than 12 hours after vial  was punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered dose more than 12 hours after vial  was punctured) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered dose more than 12 hours after vial  was punctured). On 20-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered dose more than 12 hours after vial  was punctured) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is taking unknown concomitant medications. Treatment information was not provided. It was reported that the patient received vaccine 67 hours after the 12 hours expiry that is total of 79 hours after the vials was punctured.
PT was able to self ambulate without difficulty to the observation area post vaccine. Staff noted PT was looking ahead but did not respond to any questions. HCP's called over - they noted PT was pale, still breathing but not verbally responding. This RN arrived and it was observed that PT was breathing without difficulty or adventageous breath sounds. Resp unlabored at 14/min. Skin pale, slightly diaphoretic. Pupils equal. B/P 100/70, HR (74). I was informed at this time that another RN called 911. RN spoke calmly and quietly to PT whose mother was in attendance. Mother stated PT. had "same" reaction in Drs office when getting allergic studies done. PT began to respond appropriately to staff, as EMT's arrived. They determined PT. did not need further care, or emerg. transport. PT. escorted to private area on floor & advised to rest on cot until she felt steady enough. Staff freq. checked on PT until Pt/mother left without any further issues - (approx time was 1310 when left). They were reminded to seek medical care if any other adverse actions appeared, and to make sure Pt. ate asap (Pt/mother later stated Pt. had not eaten any food before leaving home prior to injection).
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions, and concomitant medications provided. On 19-NOV-2018, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 lot # R012550 and expiration date: 25-JAN-2020 (dose, site and route of administration were not reported) for prophylaxis. No adverse effects were reported. The administered dose of vaccine was exposed to the temperature between 9 degree Celsius to 25 degree Celsius (20.3 Celsius) for 22 hours. Digital data logger was involved. There were no previous excursions reported. Sender's Comments: US-009507513-1811USA012584: US-009507513-1811USA012585: US-009507513-1811USA012586.
first shot that I received I felt like a little hives just once/ Hives on my face and I wonder it is like alarming; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date as first dose, single; second dose of BNT162B2 (Batch/Lot number was not reported), via an unspecified route of administration 12Apr2021 as second dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient felt like a little hives just once after the first shot. The second shot, the patient have had hives on the face. It was reported that it was a hives situation that like very alarming in it. The patient was wondering if there was any information on this or did someone called and noticed about the event. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever, 103 degrees F. Chills. Headache. Nausea. Diarrhea.
3MAY w/in 1 hr p/t99, crying, leg red, hot, swollen; called MD pt cool cloth on leg-redness less; slept 1/2 hrs; cont cried till seen by MD 230PM same day; given APAP p/office visit; legs sore; pt fussy;
Shoulder pain; Vertigo; Numbing in hand and feet; Tingling arms and feet/ feet and hand tingling (re-emerged); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Numbing in hand and feet), PARAESTHESIA (Tingling arms and feet/ feet and hand tingling (re-emerged)), VERTIGO (Vertigo) and ARTHRALGIA (Shoulder pain) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 31-Jan-2021.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HYPOAESTHESIA (Numbing in hand and feet) and PARAESTHESIA (Tingling arms and feet/ feet and hand tingling (re-emerged)). On 05-Mar-2021, the patient experienced VERTIGO (Vertigo). On 06-Mar-2021, the patient experienced ARTHRALGIA (Shoulder pain). On 05-Mar-2021, HYPOAESTHESIA (Numbing in hand and feet) and PARAESTHESIA (Tingling arms and feet/ feet and hand tingling (re-emerged)) had resolved. On 07-Mar-2021, VERTIGO (Vertigo) and ARTHRALGIA (Shoulder pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
1.5cm purple area of rt thigh for 2 wks no tenderness swelling beneath purple area;
Pt had both vaccines given approximately 2:30pm.  On the same day, around 4:00pm, pt started noticing that his lips were feeling "off, and wet".  He looked in the mirror and noticed that his lips were swollen and even weeping around the border. He took a Benadryl about 6:30pm and applied petroleum jelly.  He also said he took an anti-inflammatory.  He called the pharmacy about 7:20pm to let us know what was happening.  When questioned, I asked the patient if he was allergic to anything else beside sulfa and latex, as mentioned to us before the immunizations.  I asked specifically if he was allergic to eggs, and he said he had a possible egg yolk allergy that he did not mention to us.  He said he only ate egg whites.  We guessed that his allergic reaction might be due to the flu shot we gave him. I recommended he seek medical attention if his symptoms got worse.  I also said he might want to try applying a little bit of hydrocortisone cream to the border of his lips.  He said he would go see a doctor/urgent care if his condition worsened or if he started to experience other issues.
flu like symptoms, itchy burning rash left deltoid, 4 mo left axillary LAN and inc in capsular hardening of left breast implant
Muscle pain left arm 20 hours; Left foot felt like electric shock, vibrated and was stiff and out of control for 7 times; Left foot felt like electric shock, vibrated and was stiff and out of control for 7 times; Left foot felt like electric shock, vibrated and was stiff and out of control for 7 times; This is a spontaneous report from a contactable healthcare professional (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: E19262 and expiry date: unknown), via an unspecified route of administration on the left arm, on 21Jan2021 10:30 at a single dose for COVID-19 immunization. Medical history included peanut allergy. Patient was not pregnant at the time if vaccination. There were no concomitant medications. The patient experienced muscle pain left arm for 20 hours. Pain in arm muscle only when moving arm. Her left foot felt like electric shock, vibrated and was stiff and out of control for 7 times during same time as arm pain. Each episode lasting only 2 to 3 seconds. The events happened on 21Jan2021 12:00. Patient recovered from the events and had not received any treatment. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
Pt. developed high fever and convulsions(seizures)repeatedly. she was transported from 911 to regional hospital where they transported her to medical park where she was admitted.
hurts during injection; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced injection site pain (Verbatim: hurts during injection). The outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.     It was unknown if the company considered the injection site pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-APR-2023 The reporter asked if information on why Bexsero hurts during injection